Skip to main content
OpenTrials

Clinical trial condition

Diabetic Neuropathies

Explore clinical trials studying Diabetic Neuropathies. Study availability and eligibility vary by location and protocol.

400 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Diabetic Neuropathies trial results

Completed

Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy

NCT00553475

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +5 more
Locations
  • Pfizer Investigational Site Nagoya, Aichi-ken, Japan
  • Pfizer Investigational Site Chikushino-shi, Fukuoka, Japan
  • Pfizer Investigational Site Kasuga, Fukuoka, Japan
  • Pfizer Investigational Site Date-shi, Fukushima, Japan
View all 49 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia

NCT00629681

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +11 more
Locations
  • Pfizer Investigational Site Aachen, Germany
  • Pfizer Investigational Site Albstadt, Germany
  • Pfizer Investigational Site Berlin, Germany
  • Pfizer Investigational Site Berlin, Germany
View all 46 locations
View Trial Details
Completed

Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy

NCT00159679

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +5 more
Locations
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Torrance, California, United States
  • Pfizer Investigational Site Torrance, California, United States
View all 30 locations
View Trial Details
Completed

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy

NCT00553280

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +5 more
Locations
  • Pfizer Investigational Site Nagoya, Aichi-ken, Japan
  • Pfizer Investigational Site Date-shi, Fukushima, Japan
  • Pfizer Investigational Site Nihommatsu, Fukushima, Japan
  • Pfizer Investigational Site Shirakawa-shi, Fukushima, Japan
View all 27 locations
View Trial Details
Completed

A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

NCT00156078

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +5 more
Locations
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Belo Horizonte, Minas Gerais, Brazil
  • Pfizer Investigational Site Niterói, Rio de Janeiro, Brazil
  • Pfizer Investigational Site Providencia, Santiago Metropolitan, Chile
View all 35 locations
View Trial Details
Completed

Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT00143156

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +4 more
Locations
  • Pfizer Investigational Site Tuscaloosa, Alabama, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site La Mesa, California, United States
View all 54 locations
View Trial Details
Completed

Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy

NCT01057693

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Neuropathies, +9 more
Locations
  • Greystone Medical Research, LLC Birmingham, Alabama, United States
  • Neurology Clinic, PC Northport, Alabama, United States
  • Horizon Clinical Research Associates, PLLC Gilbert, Arizona, United States
  • Dedicated Clinical Research, Inc. Goodyear, Arizona, United States
View all 172 locations
View Trial Details

Related conditions